MeMed

📍 Haifa, Israel👥 122 employees💰 Last funded Jul 2018
Biotechnology Research🌐 me-med.com
Website LinkedIn
MeMed is a leading med tech and bio-convergence company, having developed innovative diagnostic host immune response testing methods that address complex clinical dilemmas and improve patient outcomes. Our mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders – at the right place and the right time.
6
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Israel
2
United States
2
Hong Kong SAR
1
Investor activity2011–2018 · investors recorded per year
2011120121201522017120181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in MeMed?
MeMed has 6 investors on record on gritt.io.
When did MeMed last raise funding?
The most recent investment in MeMed recorded on gritt.io was in July 2018.
What industry is MeMed in?
MeMed operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MeMed based?
MeMed is headquartered in Haifa, Israel.